Hatcher JP - Search Results

1

Biologics: the next-generation therapeutics for analgesia?

Hatcher JP, Chessell IP, Hughes JP. Hatcher JP, et al. Expert Rev Neurother. 2011 Nov;11(11):1653-8. doi: 10.1586/ern.11.66. Expert Rev Neurother. 2011. PMID: 22014142 Review.

2

Biologic drugs for analgesia: redefining the opportunity.

Hughes J, Hatcher JP, Chessell IP. Hughes J, et al. Among authors: hatcher jp. Curr Pharm Biotechnol. 2011 Oct;12(10):1660-70. doi: 10.2174/138920111798357384. Curr Pharm Biotechnol. 2011. PMID: 21466448 Review.

3

A new utensil in our toolbox: exploring the role of IL-6 in pain using a naturally occurring antagonist.

Chessell I, Hatcher J, Hughes J. Chessell I, et al. Pain. 2010 Nov;151(2):235-236. doi: 10.1016/j.pain.2010.06.033. Epub 2010 Jul 17. Pain. 2010. PMID: 20638791 No abstract available.

4

Mechanistic differentiation of cancer pain: a pivotal role of P2X7 is absent.

Chessell I, Hatcher J, Billinton A. Chessell I, et al. Pain. 2011 Aug;152(8):1703-1704. doi: 10.1016/j.pain.2011.04.012. Epub 2011 Apr 22. Pain. 2011. PMID: 21514729 No abstract available.

5

Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain.

Nicol LSC, Thornton P, Hatcher JP, Glover CP, Webster CI, Burrell M, Hammett K, Jones CA, Sleeman MA, Billinton A, Chessell I. Nicol LSC, et al. Among authors: hatcher jp. Pain. 2018 Mar;159(3):550-559. doi: 10.1097/j.pain.0000000000001130. Pain. 2018. PMID: 29351125 Free PMC article.

6

Transgenic models of pain: a brief review.

Hatcher JP, Chessell IP. Hatcher JP, et al. Curr Opin Investig Drugs. 2006 Jul;7(7):647-52. Curr Opin Investig Drugs. 2006. PMID: 16869119 Review.

7

Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity.

Webster CI, Hatcher J, Burrell M, Thom G, Thornton P, Gurrell I, Chessell I. Webster CI, et al. Pain. 2017 Apr;158(4):660-668. doi: 10.1097/j.pain.0000000000000810. Pain. 2017. PMID: 28009628 Free PMC article.

8

Artemin-GFRα3 interactions partially contribute to acute inflammatory hypersensitivity.

Thornton P, Hatcher JP, Robinson I, Sargent B, Franzén B, Martino G, Kitching L, Glover CP, Anderson D, Forsmo-Bruce H, Low CP, Cusdin F, Dosanjh B, Williams W, Steffen AC, Thompson S, Eklund M, Lloyd C, Chessell I, Hughes J. Thornton P, et al. Among authors: hatcher jp. Neurosci Lett. 2013 Jun 17;545:23-8. doi: 10.1016/j.neulet.2013.04.007. Epub 2013 Apr 19. Neurosci Lett. 2013. PMID: 23603259

9

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain.

Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP. Staton PC, et al. Among authors: hatcher jp. Pain. 2008 Sep 30;139(1):225-236. doi: 10.1016/j.pain.2008.04.006. Epub 2008 May 27. Pain. 2008. PMID: 18502582

10

The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.

Bingham S, Beswick PJ, Bountra C, Brown T, Campbell IB, Chessell IP, Clayton N, Collins SD, Davey PT, Goodland H, Gray N, Haslam C, Hatcher JP, Hunter AJ, Lucas F, Murkitt G, Naylor A, Pickup E, Sargent B, Summerfield SG, Stevens A, Stratton SC, Wiseman J. Bingham S, et al. Among authors: hatcher jp. J Pharmacol Exp Ther. 2005 Mar;312(3):1161-9. doi: 10.1124/jpet.104.075267. Epub 2004 Nov 30. J Pharmacol Exp Ther. 2005. PMID: 15572651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page